Artificial intelligence news and machine learning news

owkin artificial intelligence drug development

More News! 17 Jan 2018

€9M Round for AI Algorithms to Speed up Drug Development

Owkin has raised $11M(€9M) in a Series A round to fund its artificial intelligence platform for medical research and drug discovery. Owkin, based in New York and Paris, was founded in 2016 to develop machine learning algorithms that can deal with the overabundance of information in biology to optimize the drug development process. The company […]

January 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Jan 2018

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery. Based in Oxford, e-Therapeutics has the mission of reducing the time and money it costs to develop new drugs with the help of artificial intelligence. Its platform can explore large amounts of public and private databases to […]

January 16, 2018 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 2 Oct 2017

Meet the Young CEO of a PCR Workflow Automation Company

He is a young entrepreneur with a fast growing company. His software for the automation of PCR results interpretation in research laboratories has had a rocket start. Here’s his story! “I was looking for an internship for my bachelor’s degree in computer science…” His story starts like so many others, but unlike most it took […]

October 2, 2017 - 7 minutesmins - By External Contributor

News and Trends 28 Sep 2017

Everyone Wants a Piece of this Scottish Biotech’s AI

Evotec has doubled down on its investment in Exscientia: the German outfit just announced it has invested €15M to take a minority stake. Sanofi, GSK and Evotec have all jumped at the opportunity to work with Exscientia, a Scottish startup founded in 2012 and incubating in Dundee. Now, Evotec has gone beyond the initial immuno-oncology deal […]

September 28, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 27 Sep 2017

German Researchers’ Algorithm Can Predict New Targets for Existing Drugs

An algorithm based on the brain’s self-organizing capacity has been developed in Germany that could combat the rising costs of drug development. A team at TU Dresden has pioneered an algorithm that exploits the self-organization of the brain to predict new drug targets, without the need for extra biological or molecular information. The study, published in Briefings […]

September 27, 2017 - 3 minutesmins - By Alex Dale

Sophia Genetics artificial intelligence fundraising

News and Trends 13 Sep 2017

Series D Boost will Bring Artificial Intelligence to Diagnostics Worldwide

Sophia Genetics has raised $30M (€25M) in Series D that will be directed to growing and improving its artificial intelligence platform for genetic diagnostics. The Swiss company Sophia Genetics has announced today a new round of funding, led by Balderton Capital, and joined by 360º Capital Partners and existing investors Invoke Capital and Alychlo. The […]

September 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Jul 2017

Finnish AI Biotech Raises €14M to Open the Bottleneck of Next-Generation Sequencing

Blueprint Genetics has raised €14M to boost its genetic diagnostics platform, using artificial intelligence to interpret next-generation sequencing data. Based in Helsinki, Finland, Blueprint Genetics is a startup that addresses the main bottleneck of genetic testing through next-generation sequencing (NGS), the interpretation of massive volumes of data, with the aid of artificial intelligence (AI). Its […]

July 11, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 3 Jul 2017

Scottish AI Biotech Recruits Another Pharma Partner in €37M Deal

After Sanofi recruited Exscientia in a €250M deal last May, GSK has taken an interest in the startup and invested in a collaboration of its own. Artificial intelligence has been carving out a niche for itself in biotech, and Exscientia is fast establishing itself as a key player in the field. In May, the company signed a […]

July 3, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 9 May 2017

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

As part of the deal with Sanofi, Exscientia will tackle the discovery and design of new bispecific drugs using artificial intelligence algorithms. Exscientia, based in Scotland, is a company that uses artificial intelligence (AI) to develop new drugs faster. Its edge-cutting technology has caught the attention of Sanofi, which is offering Exscientia research funding and […]

May 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

BenevolentAI Artificial Intelligence Fundraising

Interview 20 Mar 2017

Machines are Helping Healthcare: An Interview with their Biotech Leader

BenevolentAI is leading the charge in artificial intelligence. We talked to Jackie Hunter, who is the CEO of the company’s bioscience arm, BenevolentBio. Jackie Hunter has had quite an impressive career! After defending her PhD in psychology, she transitioned to GSK, where she clocked nearly 20 years in various leadership positions — Director while the […]

March 20, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 26 Nov 2016

Fruit Flies are the Artists behind these Astounding Exhibitions

The Fly Printer by Laura Beloff transforms fruit flies into artists behind pieces that highlight the limits of always making humans the point of reference in technology. Fruit flies are a very common model organism for experimentation in biotech. Now, a piece of art at the Open Fields exhibition in Riga is inverting the roles […]

November 26, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Nov 2016

British Artificial Intelligence will soon run Clinical Trials

Artificial Intelligence can make clinical trials cheaper and faster, and this British start-up is about to start testing its technology to optimize drug development. BenevolentAI is a London start-up that specializes in artificial intelligence (AI); its BenevolentBio division, formerly Stratified Medical, applies AI to human health and biotech. Its baby is a technology that could speed […]

November 9, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial intelligence

€9M Round for AI Algorithms to Speed up Drug Development

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

Meet the Young CEO of a PCR Workflow Automation Company

Everyone Wants a Piece of this Scottish Biotech’s AI

German Researchers’ Algorithm Can Predict New Targets for Existing Drugs

Series D Boost will Bring Artificial Intelligence to Diagnostics Worldwide

Finnish AI Biotech Raises €14M to Open the Bottleneck of Next-Generation Sequencing

Scottish AI Biotech Recruits Another Pharma Partner in €37M Deal

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

Machines are Helping Healthcare: An Interview with their Biotech Leader

Fruit Flies are the Artists behind these Astounding Exhibitions

British Artificial Intelligence will soon run Clinical Trials

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!